Improving post-approval efficiencies and reducing costs for a global biopharmaceutical leader

A Top 20 biopharmaceutical company sought to free its highly qualified regulatory affairs professionals from routine regulatory maintenance work to focus on innovating and launching new brands to drive the business forward. Today, Cencora’s global scale and local expertise supports the company’s goal of maximizing market availability of more than 80 products globally, while achieving a 20% reduction in internal workload.